Table of Content

1 Oncology Injection Drug Market Overview
1.1 Product Overview and Scope of Oncology Injection Drug
1.2 Oncology Injection Drug Segment by Type
1.2.1 Global Oncology Injection Drug Market Value Comparison by Type (2024-2034)
1.2.2 Organs
1.2.3 Central Nervous System
1.2.4 Circulatory/Musculoskeletal System
1.2.5 Other
1.3 Oncology Injection Drug Segment by Application
1.3.1 Global Oncology Injection Drug Market Value by Application: (2024-2034)
1.3.2 Lymphoma
1.3.3 Myeloma
1.3.4 Prostate Cancer
1.3.5 Other
1.4 Global Oncology Injection Drug Market Size Estimates and Forecasts
1.4.1 Global Oncology Injection Drug Revenue 2018-2034
1.4.2 Global Oncology Injection Drug Sales 2018-2034
1.4.3 Global Oncology Injection Drug Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Oncology Injection Drug Market Competition by Manufacturers
2.1 Global Oncology Injection Drug Sales Market Share by Manufacturers (2018-2024)
2.2 Global Oncology Injection Drug Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Oncology Injection Drug Average Price by Manufacturers (2018-2024)
2.4 Global Oncology Injection Drug Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Oncology Injection Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oncology Injection Drug, Product Type & Application
2.7 Oncology Injection Drug Market Competitive Situation and Trends
2.7.1 Oncology Injection Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oncology Injection Drug Players Market Share by Revenue
2.7.3 Global Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oncology Injection Drug Retrospective Market Scenario by Region
3.1 Global Oncology Injection Drug Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Oncology Injection Drug Global Oncology Injection Drug Sales by Region: 2018-2034
3.2.1 Global Oncology Injection Drug Sales by Region: 2018-2024
3.2.2 Global Oncology Injection Drug Sales by Region: 2024-2034
3.3 Global Oncology Injection Drug Global Oncology Injection Drug Revenue by Region: 2018-2034
3.3.1 Global Oncology Injection Drug Revenue by Region: 2018-2024
3.3.2 Global Oncology Injection Drug Revenue by Region: 2024-2034
3.4 North America Oncology Injection Drug Market Facts & Figures by Country
3.4.1 North America Oncology Injection Drug Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Oncology Injection Drug Sales by Country (2018-2034)
3.4.3 North America Oncology Injection Drug Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Oncology Injection Drug Market Facts & Figures by Country
3.5.1 Europe Oncology Injection Drug Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Oncology Injection Drug Sales by Country (2018-2034)
3.5.3 Europe Oncology Injection Drug Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oncology Injection Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Oncology Injection Drug Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Oncology Injection Drug Sales by Country (2018-2034)
3.6.3 Asia Pacific Oncology Injection Drug Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Oncology Injection Drug Market Facts & Figures by Country
3.7.1 Latin America Oncology Injection Drug Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Oncology Injection Drug Sales by Country (2018-2034)
3.7.3 Latin America Oncology Injection Drug Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oncology Injection Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Oncology Injection Drug Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Oncology Injection Drug Sales by Country (2018-2034)
3.8.3 Middle East and Africa Oncology Injection Drug Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Oncology Injection Drug Sales by Type (2018-2034)
4.1.1 Global Oncology Injection Drug Sales by Type (2018-2024)
4.1.2 Global Oncology Injection Drug Sales by Type (2024-2034)
4.1.3 Global Oncology Injection Drug Sales Market Share by Type (2018-2034)
4.2 Global Oncology Injection Drug Revenue by Type (2018-2034)
4.2.1 Global Oncology Injection Drug Revenue by Type (2018-2024)
4.2.2 Global Oncology Injection Drug Revenue by Type (2024-2034)
4.2.3 Global Oncology Injection Drug Revenue Market Share by Type (2018-2034)
4.3 Global Oncology Injection Drug Price by Type (2018-2034)
5 Segment by Application
5.1 Global Oncology Injection Drug Sales by Application (2018-2034)
5.1.1 Global Oncology Injection Drug Sales by Application (2018-2024)
5.1.2 Global Oncology Injection Drug Sales by Application (2024-2034)
5.1.3 Global Oncology Injection Drug Sales Market Share by Application (2018-2034)
5.2 Global Oncology Injection Drug Revenue by Application (2018-2034)
5.2.1 Global Oncology Injection Drug Revenue by Application (2018-2024)
5.2.2 Global Oncology Injection Drug Revenue by Application (2024-2034)
5.2.3 Global Oncology Injection Drug Revenue Market Share by Application (2018-2034)
5.3 Global Oncology Injection Drug Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Taj Oncology
6.1.1 Taj Oncology Corporation Information
6.1.2 Taj Oncology Description and Business Overview
6.1.3 Taj Oncology Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Taj Oncology Oncology Injection Drug Product Portfolio
6.1.5 Taj Oncology Recent Developments/Updates
6.2 S.G. Biopharm
6.2.1 S.G. Biopharm Corporation Information
6.2.2 S.G. Biopharm Description and Business Overview
6.2.3 S.G. Biopharm Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
6.2.4 S.G. Biopharm Oncology Injection Drug Product Portfolio
6.2.5 S.G. Biopharm Recent Developments/Updates
6.3 AdvaCare
6.3.1 AdvaCare Corporation Information
6.3.2 AdvaCare Description and Business Overview
6.3.3 AdvaCare Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
6.3.4 AdvaCare Oncology Injection Drug Product Portfolio
6.3.5 AdvaCare Recent Developments/Updates
6.4 Merrimack
6.4.1 Merrimack Corporation Information
6.4.2 Merrimack Description and Business Overview
6.4.3 Merrimack Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Merrimack Oncology Injection Drug Product Portfolio
6.4.5 Merrimack Recent Developments/Updates
6.5 Celgene
6.5.1 Celgene Corporation Information
6.5.2 Celgene Description and Business Overview
6.5.3 Celgene Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Celgene Oncology Injection Drug Product Portfolio
6.5.5 Celgene Recent Developments/Updates
6.6 Allos Therapeutics
6.6.1 Allos Therapeutics Corporation Information
6.6.2 Allos Therapeutics Description and Business Overview
6.6.3 Allos Therapeutics Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Allos Therapeutics Oncology Injection Drug Product Portfolio
6.6.5 Allos Therapeutics Recent Developments/Updates
6.7 Ferring Pharmaceuticals
6.6.1 Ferring Pharmaceuticals Corporation Information
6.6.2 Ferring Pharmaceuticals Description and Business Overview
6.6.3 Ferring Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Ferring Pharmaceuticals Oncology Injection Drug Product Portfolio
6.7.5 Ferring Pharmaceuticals Recent Developments/Updates
6.8 Genzyme
6.8.1 Genzyme Corporation Information
6.8.2 Genzyme Description and Business Overview
6.8.3 Genzyme Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Genzyme Oncology Injection Drug Product Portfolio
6.8.5 Genzyme Recent Developments/Updates
6.9 Eli Lilly
6.9.1 Eli Lilly Corporation Information
6.9.2 Eli Lilly Description and Business Overview
6.9.3 Eli Lilly Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Eli Lilly Oncology Injection Drug Product Portfolio
6.9.5 Eli Lilly Recent Developments/Updates
6.10 Praecis Pharmaceuticals
6.10.1 Praecis Pharmaceuticals Corporation Information
6.10.2 Praecis Pharmaceuticals Description and Business Overview
6.10.3 Praecis Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Praecis Pharmaceuticals Oncology Injection Drug Product Portfolio
6.10.5 Praecis Pharmaceuticals Recent Developments/Updates
6.11 Millennium Pharmaceuticals
6.11.1 Millennium Pharmaceuticals Corporation Information
6.11.2 Millennium Pharmaceuticals Oncology Injection Drug Description and Business Overview
6.11.3 Millennium Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Millennium Pharmaceuticals Oncology Injection Drug Product Portfolio
6.11.5 Millennium Pharmaceuticals Recent Developments/Updates
6.12 Debiopharm
6.12.1 Debiopharm Corporation Information
6.12.2 Debiopharm Oncology Injection Drug Description and Business Overview
6.12.3 Debiopharm Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Debiopharm Oncology Injection Drug Product Portfolio
6.12.5 Debiopharm Recent Developments/Updates
6.13 Alza
6.13.1 Alza Corporation Information
6.13.2 Alza Oncology Injection Drug Description and Business Overview
6.13.3 Alza Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Alza Oncology Injection Drug Product Portfolio
6.13.5 Alza Recent Developments/Updates
6.14 CordenPharma
6.14.1 CordenPharma Corporation Information
6.14.2 CordenPharma Oncology Injection Drug Description and Business Overview
6.14.3 CordenPharma Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
6.14.4 CordenPharma Oncology Injection Drug Product Portfolio
6.14.5 CordenPharma Recent Developments/Updates
6.15 Pharmascience
6.15.1 Pharmascience Corporation Information
6.15.2 Pharmascience Oncology Injection Drug Description and Business Overview
6.15.3 Pharmascience Oncology Injection Drug Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Pharmascience Oncology Injection Drug Product Portfolio
6.15.5 Pharmascience Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oncology Injection Drug Industry Chain Analysis
7.2 Oncology Injection Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oncology Injection Drug Production Mode & Process
7.4 Oncology Injection Drug Sales and Marketing
7.4.1 Oncology Injection Drug Sales Channels
7.4.2 Oncology Injection Drug Distributors
7.5 Oncology Injection Drug Customers
8 Oncology Injection Drug Market Dynamics
8.1 Oncology Injection Drug Industry Trends
8.2 Oncology Injection Drug Market Drivers
8.3 Oncology Injection Drug Market Challenges
8.4 Oncology Injection Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Oncology Injection Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Oncology Injection Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Oncology Injection Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global Oncology Injection Drug Sales (K Pcs) of Key Manufacturers (2018-2024)
Table 5. Global Oncology Injection Drug Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Oncology Injection Drug Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Oncology Injection Drug Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Oncology Injection Drug Average Price (USD/Pcs) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Oncology Injection Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Oncology Injection Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oncology Injection Drug, Product Type & Application
Table 12. Global Key Manufacturers of Oncology Injection Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oncology Injection Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Injection Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oncology Injection Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Oncology Injection Drug Sales by Region (2018-2024) & (K Pcs)
Table 18. Global Oncology Injection Drug Sales Market Share by Region (2018-2024)
Table 19. Global Oncology Injection Drug Sales by Region (2024-2034) & (K Pcs)
Table 20. Global Oncology Injection Drug Sales Market Share by Region (2024-2034)
Table 21. Global Oncology Injection Drug Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Oncology Injection Drug Revenue Market Share by Region (2018-2024)
Table 23. Global Oncology Injection Drug Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Oncology Injection Drug Revenue Market Share by Region (2024-2034)
Table 25. North America Oncology Injection Drug Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Oncology Injection Drug Sales by Country (2018-2024) & (K Pcs)
Table 27. North America Oncology Injection Drug Sales by Country (2024-2034) & (K Pcs)
Table 28. North America Oncology Injection Drug Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Oncology Injection Drug Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Oncology Injection Drug Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Oncology Injection Drug Sales by Country (2018-2024) & (K Pcs)
Table 32. Europe Oncology Injection Drug Sales by Country (2024-2034) & (K Pcs)
Table 33. Europe Oncology Injection Drug Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Oncology Injection Drug Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Oncology Injection Drug Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Oncology Injection Drug Sales by Region (2018-2024) & (K Pcs)
Table 37. Asia Pacific Oncology Injection Drug Sales by Region (2024-2034) & (K Pcs)
Table 38. Asia Pacific Oncology Injection Drug Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Oncology Injection Drug Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Oncology Injection Drug Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Oncology Injection Drug Sales by Country (2018-2024) & (K Pcs)
Table 42. Latin America Oncology Injection Drug Sales by Country (2024-2034) & (K Pcs)
Table 43. Latin America Oncology Injection Drug Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Oncology Injection Drug Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Oncology Injection Drug Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Oncology Injection Drug Sales by Country (2018-2024) & (K Pcs)
Table 47. Middle East & Africa Oncology Injection Drug Sales by Country (2024-2034) & (K Pcs)
Table 48. Middle East & Africa Oncology Injection Drug Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Oncology Injection Drug Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Oncology Injection Drug Sales (K Pcs) by Type (2018-2024)
Table 51. Global Oncology Injection Drug Sales (K Pcs) by Type (2024-2034)
Table 52. Global Oncology Injection Drug Sales Market Share by Type (2018-2024)
Table 53. Global Oncology Injection Drug Sales Market Share by Type (2024-2034)
Table 54. Global Oncology Injection Drug Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Oncology Injection Drug Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Oncology Injection Drug Revenue Market Share by Type (2018-2024)
Table 57. Global Oncology Injection Drug Revenue Market Share by Type (2024-2034)
Table 58. Global Oncology Injection Drug Price (USD/Pcs) by Type (2018-2024)
Table 59. Global Oncology Injection Drug Price (USD/Pcs) by Type (2024-2034)
Table 60. Global Oncology Injection Drug Sales (K Pcs) by Application (2018-2024)
Table 61. Global Oncology Injection Drug Sales (K Pcs) by Application (2024-2034)
Table 62. Global Oncology Injection Drug Sales Market Share by Application (2018-2024)
Table 63. Global Oncology Injection Drug Sales Market Share by Application (2024-2034)
Table 64. Global Oncology Injection Drug Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Oncology Injection Drug Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Oncology Injection Drug Revenue Market Share by Application (2018-2024)
Table 67. Global Oncology Injection Drug Revenue Market Share by Application (2024-2034)
Table 68. Global Oncology Injection Drug Price (USD/Pcs) by Application (2018-2024)
Table 69. Global Oncology Injection Drug Price (USD/Pcs) by Application (2024-2034)
Table 70. Taj Oncology Corporation Information
Table 71. Taj Oncology Description and Business Overview
Table 72. Taj Oncology Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 73. Taj Oncology Oncology Injection Drug Product
Table 74. Taj Oncology Recent Developments/Updates
Table 75. S.G. Biopharm Corporation Information
Table 76. S.G. Biopharm Description and Business Overview
Table 77. S.G. Biopharm Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 78. S.G. Biopharm Oncology Injection Drug Product
Table 79. S.G. Biopharm Recent Developments/Updates
Table 80. AdvaCare Corporation Information
Table 81. AdvaCare Description and Business Overview
Table 82. AdvaCare Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 83. AdvaCare Oncology Injection Drug Product
Table 84. AdvaCare Recent Developments/Updates
Table 85. Merrimack Corporation Information
Table 86. Merrimack Description and Business Overview
Table 87. Merrimack Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 88. Merrimack Oncology Injection Drug Product
Table 89. Merrimack Recent Developments/Updates
Table 90. Celgene Corporation Information
Table 91. Celgene Description and Business Overview
Table 92. Celgene Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 93. Celgene Oncology Injection Drug Product
Table 94. Celgene Recent Developments/Updates
Table 95. Allos Therapeutics Corporation Information
Table 96. Allos Therapeutics Description and Business Overview
Table 97. Allos Therapeutics Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 98. Allos Therapeutics Oncology Injection Drug Product
Table 99. Allos Therapeutics Recent Developments/Updates
Table 100. Ferring Pharmaceuticals Corporation Information
Table 101. Ferring Pharmaceuticals Description and Business Overview
Table 102. Ferring Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 103. Ferring Pharmaceuticals Oncology Injection Drug Product
Table 104. Ferring Pharmaceuticals Recent Developments/Updates
Table 105. Genzyme Corporation Information
Table 106. Genzyme Description and Business Overview
Table 107. Genzyme Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 108. Genzyme Oncology Injection Drug Product
Table 109. Genzyme Recent Developments/Updates
Table 110. Eli Lilly Corporation Information
Table 111. Eli Lilly Description and Business Overview
Table 112. Eli Lilly Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. Eli Lilly Oncology Injection Drug Product
Table 114. Eli Lilly Recent Developments/Updates
Table 115. Praecis Pharmaceuticals Corporation Information
Table 116. Praecis Pharmaceuticals Description and Business Overview
Table 117. Praecis Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Praecis Pharmaceuticals Oncology Injection Drug Product
Table 119. Praecis Pharmaceuticals Recent Developments/Updates
Table 120. Millennium Pharmaceuticals Corporation Information
Table 121. Millennium Pharmaceuticals Description and Business Overview
Table 122. Millennium Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. Millennium Pharmaceuticals Oncology Injection Drug Product
Table 124. Millennium Pharmaceuticals Recent Developments/Updates
Table 125. Debiopharm Corporation Information
Table 126. Debiopharm Description and Business Overview
Table 127. Debiopharm Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Debiopharm Oncology Injection Drug Product
Table 129. Debiopharm Recent Developments/Updates
Table 130. Alza Corporation Information
Table 131. Alza Description and Business Overview
Table 132. Alza Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. Alza Oncology Injection Drug Product
Table 134. Alza Recent Developments/Updates
Table 135. CordenPharma Corporation Information
Table 136. CordenPharma Description and Business Overview
Table 137. CordenPharma Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 138. CordenPharma Oncology Injection Drug Product
Table 139. CordenPharma Recent Developments/Updates
Table 140. Pharmascience Corporation Information
Table 141. Pharmascience Description and Business Overview
Table 142. Pharmascience Oncology Injection Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 143. Pharmascience Oncology Injection Drug Product
Table 144. Pharmascience Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Oncology Injection Drug Distributors List
Table 148. Oncology Injection Drug Customers List
Table 149. Oncology Injection Drug Market Trends
Table 150. Oncology Injection Drug Market Drivers
Table 151. Oncology Injection Drug Market Challenges
Table 152. Oncology Injection Drug Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oncology Injection Drug
Figure 2. Global Oncology Injection Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Oncology Injection Drug Market Share by Type in 2022 & 2034
Figure 4. Organs Product Picture
Figure 5. Central Nervous System Product Picture
Figure 6. Circulatory/Musculoskeletal System Product Picture
Figure 7. Other Product Picture
Figure 8. Global Oncology Injection Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Oncology Injection Drug Market Share by Application in 2022 & 2034
Figure 10. Lymphoma
Figure 11. Myeloma
Figure 12. Prostate Cancer
Figure 13. Other
Figure 14. Global Oncology Injection Drug Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global Oncology Injection Drug Market Size (2018-2034) & (US$ Million)
Figure 16. Global Oncology Injection Drug Sales (2018-2034) & (K Pcs)
Figure 17. Global Oncology Injection Drug Average Price (USD/Pcs) & (2018-2034)
Figure 18. Oncology Injection Drug Report Years Considered
Figure 19. Oncology Injection Drug Sales Share by Manufacturers in 2022
Figure 20. Global Oncology Injection Drug Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Oncology Injection Drug Players: Market Share by Revenue in 2022
Figure 22. Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Oncology Injection Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 24. North America Oncology Injection Drug Sales Market Share by Country (2018-2034)
Figure 25. North America Oncology Injection Drug Revenue Market Share by Country (2018-2034)
Figure 26. U.S. Oncology Injection Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. Canada Oncology Injection Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. Europe Oncology Injection Drug Sales Market Share by Country (2018-2034)
Figure 29. Europe Oncology Injection Drug Revenue Market Share by Country (2018-2034)
Figure 30. Germany Oncology Injection Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. France Oncology Injection Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. U.K. Oncology Injection Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Italy Oncology Injection Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Russia Oncology Injection Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Asia Pacific Oncology Injection Drug Sales Market Share by Region (2018-2034)
Figure 36. Asia Pacific Oncology Injection Drug Revenue Market Share by Region (2018-2034)
Figure 37. China Oncology Injection Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Japan Oncology Injection Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. South Korea Oncology Injection Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. India Oncology Injection Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Australia Oncology Injection Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Taiwan Oncology Injection Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Indonesia Oncology Injection Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Thailand Oncology Injection Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Malaysia Oncology Injection Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Philippines Oncology Injection Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Latin America Oncology Injection Drug Sales Market Share by Country (2018-2034)
Figure 48. Latin America Oncology Injection Drug Revenue Market Share by Country (2018-2034)
Figure 49. Mexico Oncology Injection Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Brazil Oncology Injection Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Argentina Oncology Injection Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Middle East & Africa Oncology Injection Drug Sales Market Share by Country (2018-2034)
Figure 53. Middle East & Africa Oncology Injection Drug Revenue Market Share by Country (2018-2034)
Figure 54. Turkey Oncology Injection Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. Saudi Arabia Oncology Injection Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. U.A.E Oncology Injection Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 57. Global Sales Market Share of Oncology Injection Drug by Type (2018-2034)
Figure 58. Global Revenue Market Share of Oncology Injection Drug by Type (2018-2034)
Figure 59. Global Oncology Injection Drug Price (USD/Pcs) by Type (2018-2034)
Figure 60. Global Sales Market Share of Oncology Injection Drug by Application (2018-2034)
Figure 61. Global Revenue Market Share of Oncology Injection Drug by Application (2018-2034)
Figure 62. Global Oncology Injection Drug Price (USD/Pcs) by Application (2018-2034)
Figure 63. Oncology Injection Drug Value Chain
Figure 64. Oncology Injection Drug Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed